Standout Papers

Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme 2007 2026 2013 2019 1.0k
  1. Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme (2007)
    James J. Vredenburgh, Annick Desjardins et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 11 from Science/Nature 99 standout
Sub-graph 1 of 18

Citing Papers

Glioblastoma Therapy: Past, Present and Future
2024 Standout
Theranostic Fluorescent Probes
2024 Standout
83 intermediate papers

Works of Leighann Bailey being referenced

Bevacizumab and daily temozolomide for recurrent glioblastoma
2011
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
2007 Standout
and 5 more

Author Peers

Author Last Decade Papers Cites
Leighann Bailey 1251 504 444 459 13 1.5k
Dana Cernea 1380 545 476 584 16 2.0k
Kraig Moore 980 385 327 382 8 1.3k
Mary Jo Gleason 1134 551 257 528 15 1.5k
Paul Duic 983 387 327 375 5 1.2k
Y. Marie 1091 412 547 717 33 1.6k
Jane Rabbitt 1111 468 285 432 29 1.5k
Nancy Garren 993 390 323 356 4 1.2k
V. Blatt 1279 595 289 368 17 1.4k
J.-C. Tonn 703 297 226 531 23 1.3k
Sandra Tourt-Uhlig 792 353 229 501 12 1.3k

All Works

Loading papers...

Rankless by CCL
2026